Real‐world brain imaging in a population‐based cohort enables accurate markers for dementia is a research paper published in Alzheimer s & Dementia (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Research Council of Finland
Grant: 338647
Intelligent bone – Deep learning to support diagnostics of osteoporosis and fracture risk prediction from dual-energy absorptiometry
Research Council of Finland
Grant: 346934
PRIMAL: Robust Framework for PRedictive IMage AnaLysis of Brain Change
Research Council of Finland
Grant: 351849
Pattern-Cog: Personalized aging pattern for early risk detection and prevention of cognitive impairment and dementia in cognitively healthy individuals
Research Council of Finland
Grant: 358944
Flagship of Advanced Mathematics for Sensing, Imaging and Modelling
National Institutes of Health
Grant: U19 AG024904
Ane and Signe Gyllenberg's Foundation
Grant: 6671
EU Innovative Health Initiative Joint Undertaking AD-RIDDLE
Grant: 101132933
REAL-WORLD IMPLEMENTATION, DEPLOYMENT AND VALIDATION OF EARLY DETECTION TOOLS AND LIFESTYLE ENHANCEMENT
NIA NIH HHS
Grant: U01 AG024904
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 3U19AG024904-18S3
Alzheimer's Disease Neuroimaging Initiative (ADNI4)
AbbVie
CereSpir, Inc.
Elan Pharmaceuticals, Inc.
IXICO Ltd.
Johnson & Johnson Pharmaceutical Research & Development
Piramal Imaging
State Research Funding of Kuopio University Hospital Catchment Area
Biogen
Eli Lilly and Company
NeuroRx Research
Päivikki ja Sakari Sohlbergin Säätiö
Transition Therapeutics
University of Eastern Finland Bioinformatics Center
Bristol-Myers Squibb
Lumosity
National Institute of Biomedical Imaging and Bioengineering
Bristol-Myers Squibb Company
Cogstate
Fujirebio
Araclon Biotech
Fujirebio US
Meso Scale Diagnostics
NIBIB NIH HHS
Novartis Pharmaceuticals Corporation
Pfizer Inc.
Servier
Alzheimer's Association
Alzheimer's Drug Discovery Foundation
Alzheimer's Association
Janssen Alzheimer Immunotherapy Research & Development
National Institute on Aging
Neurotrack Technologies
Päivikki and Sakari Sohlberg Foundation
Alzheimer's Drug Discovery Foundation
GE Healthcare
Pfizer
Takeda Pharmaceutical Company
Alzheimer's Association
Janssen Alzheimer Immunotherapy Research & Development
NIBIB NIH HHS
Meso Scale Diagnostics
Eli Lilly and Company
Biogen
Päivikki and Sakari Sohlberg Foundation
Alzheimer's Drug Discovery Foundation
Servier
Lumosity
Bristol-Myers Squibb Company
Piramal Imaging
Takeda Pharmaceutical Company
Araclon Biotech
Novartis Pharmaceuticals Corporation
CereSpir, Inc.
GE Healthcare
Johnson & Johnson Pharmaceutical Research & Development
AbbVie
Transition Therapeutics
State Research Funding of Kuopio University Hospital Catchment Area
Cogstate
University of Eastern Finland Bioinformatics Center
Pfizer Inc.
Elan Pharmaceuticals, Inc.
IXICO Ltd.
NeuroRx Research
Fujirebio
Neurotrack Technologies
FWCI
0.00
Citation Percentile
0.2%
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals